Company-diagnostics Stock News

Co-Diagnostics, Inc. (NASDAQ:CODX) was the recipient of some unusual options trading on Wednesday. Investors bought 7,627 call options on the company. This represents an increase of 478% compared to the typical daily volume of 1,319 call options. CODX opened at $9.41 on Friday. The stock has a market capitalization of $271.85 million, a P/E ratio []

Co-Diagnostics (NASDAQ:CODX)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a research report issued on Thursday, TipRanks reports. They presently have a $15.00 price objective on the stock. HC Wainwright’s price objective indicates a potential upside of 60.94% from the company’s current price. Several other equities research analysts have also […]

Definitive merger agreements provide the Company with all existing and future assets, future product iterations, and intellectual property rights of the platform, creating a fully integrated product line and streamlining commercialization

Develops products to detect infectious diseases in humans and animals Offers Logix Smart coronavirus detection test in US and globally Amassed balance sheet of $72.4 million What Co-Diagnostics does:

Co-Diagnostics (NASDAQ:CODX) Inc announced that it has signed agreements to acquire Idaho Molecular Inc and Advance Conceptions Inc for the development of its upcoming at-home/point-of-care diagnost

Co-Diagnostics (NASDAQ:CODX) Inc announced that it has signed agreements to acquire Idaho Molecular Inc and Advance Conceptions Inc for the development of its upcoming at-home/point-of-care diagnost

With the omicron variant presenting uncertainties regarding how governments will react, here are some stocks to buy to counter that risk. The post 7 Stocks to Buy to Hedge Against Omicron Variant Risk

Pfizer Inc. (NYSE:PFE) with the stream of 1.34% also noticed, India Co-Diagnostics, Inc. (NASDAQ:CODX) encountered a rapid change of -1.97% in the last hour of Fridays trading session. Pfizer Inc. The post Do the Stock Experienced Heavy Trading? Pfizer Inc. (NYSE:PFE), Co-Diagnostics, Inc. (NASDAQ:CODX) appeared first on Stocks Equity .

Co-Diagnostics (NASDAQ:CODX) Inc said it has partnered with TiiCKER—a consumer shareholder loyalty platform—to increase its connection to retail investors.  The Salt Lake City-based company has

Select Medical (SEM) is focused on making strategic acquisitions to boost its business through inorganic growth.

Co-Diagnostics (NASDAQ:CODX) and Asensus Surgical (NYSE:ASXC) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, earnings and valuation. Insider and Institutional Ownership 25.6% of Co-Diagnostics shares are held by institutional investors. Comparatively, 24.8% of []

Price T Rowe Associates Inc. MD cut its stake in Co-Diagnostics, Inc. (NASDAQ:CODX) by 16.7% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 39,600 shares of the companys stock after selling 7,929 shares during the period. Price T Rowe Associates []